All lobbying filings

THE MCMANUS GROUP

Lobbying for BRISTOL-MYERS SQUIBB · Biopharmaceutical Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $80,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 1

HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Lobbying activity 2

Medicare/Medicaid

Policies related to the Most Favored Nation Drug Pricing Model Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R.4299 - Protecting Patient Access to Cancer and Complex Therapies Act Issues related to Center for Medicare and Medicaid Innovation (CMMI) guardrails

Health Issues

Issues related to reforming and increasing transparency within the 340B Drug Pricing Program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.